Total Credits: 1.25 including 1.25 AOA Category 1-A Credit(s), 1.25 AMA PRA Category 1 Credit(s)™
Fatty Liver: Do We Need to Worry About It?
David Leff, DO
Dr. Leff discloses he is on the Speakers' Bureau for Abbvie, Alfa Sigma, Allergan, Gilead and Salix.
All relevant financial relationships have been mitigated.
Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
The AOMA designates this activity for a maximum of 1.25 hour of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AOMA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
GRIEVANCE POLICY
All grievances should be forwarded to the AOMA Executive Director, Matt Helms by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 3901 W. Peoria Ave., Suite C102-158, Phoenix, AZ 85029 or by email info@azosteo.org.
| Fatty Liver Do We Need to Worry About it? (2.7 MB) | 37 Pages | Available after Purchase |
David Leff, DO is a board certified gastroenterologist in private practice in Mesa, Arizona. He is an Adjunct Assistant Professor, Division of Clinical Education, Midwestern University - Arizona College of Osteopathic Medicine. Dr Leff is a graduate of Des Moines University and he completed his Internal Medicine residency and Gastroenterology fellowship at the Western Pennsylvania Hospital in Pittsburgh. During his fellowship he was involved with early Hepatitis C treatment options. He currently serves on the Medical Advisory Committee for the American Liver Foundation – Arizona Chapter. Dr. Leff speaks for a number of different pharmaceutical companies on the topics of hepatitis C and irritable bowel syndrome.
Dr. Leff discloses that he is a member of the Speakers Bureau for Gilead Sciences and AbbVie.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|